(19)
(11) EP 4 243 805 A1

(12)

(43) Date of publication:
20.09.2023 Bulletin 2023/38

(21) Application number: 21762002.0

(22) Date of filing: 06.08.2021
(51) International Patent Classification (IPC): 
A61K 31/201(2006.01)
A61P 31/14(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/201; A61K 45/06; A61P 31/14
(86) International application number:
PCT/EP2021/072107
(87) International publication number:
WO 2022/029334 (10.02.2022 Gazette 2022/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.08.2020 EP 20190151
06.04.2021 EP 21167071

(71) Applicant: Gbiotech S.À.R.L.
1292 Chambésy (CH)

(72) Inventor:
  • FITZGERALD, Daniel Joseph
    1227 Carouge (CH)

(74) Representative: Habermann, Hruschka & Schnabel 
Patentanwälte Montgelasstraße 2
81679 München
81679 München (DE)

   


(54) COMBINATION THERAPIES FOR TREATING CORONAVIRUS INFECTION